TRV GP IV, LLC

Key Holdings

The portfolio is composed entirely of Tango Therapeutics, Inc., which accounts for 100% of the total assets at a valuation of $116.46 million. The position consists of 13.86 million shares. The fact that this is the sole holding indicates that TRV GP IV, LLC is likely a specialized vehicle or a subsidiary entity created specifically to hold this asset, rather than a generalist fund managing a broad basket of securities. The reduction in the position’s value (down $30.14M or 17.8% in share count/value) suggests the manager is actively monetizing the position or reducing exposure, possibly due to liquidity needs or a shift in the investment thesis.